APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Concentration Detection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Concentration Detection Market Analysis and Forecast 2026-2032

25 December 2025207 pages

Choose your research edition.

Industry ResearchDrug Concentration Detection Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Concentration Detection Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Drug Concentration Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Concentration Detection Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Concentration Detection Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Drug Concentration Detection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Concentration Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Concentration Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Concentration Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Concentration Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Concentration Detection include Thermo Fisher Scientific, Abbott, ACROBiosystems, bioMerieux, Bio-Rad Laboratories, Bühlmann Laboratories, Danaher, Randox Laboratories and Roche, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Concentration Detection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Concentration Detection, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Concentration Detection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Concentration Detection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Concentration Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Concentration Detection revenue, projected growth trends, production technology, application and end-user industry.

Drug Concentration Detection Segment by Company

Thermo Fisher Scientific

Abbott

ACROBiosystems

bioMerieux

Bio-Rad Laboratories

Bühlmann Laboratories

Danaher

Randox Laboratories

Roche

Sekisui Medical

Siemens Healthineers

Shanghai Genext Medical Technology

Beijing Chromai

Beijing IPHASE

Beijing Diagreat

Beijing Haosi Biotech

Drug Concentration Detection Segment by Type

Blood Detection

Urine Detection

Others

Drug Concentration Detection Segment by Application

Hospital

Clinic

Others

Drug Concentration Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Concentration Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Concentration Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Concentration Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Concentration Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Concentration Detection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Concentration Detection revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Concentration Detection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Blood Detection Major Player Table 3. Urine Detection Major Player Table 4. Others Major Player Table 5. Global Drug Concentration Detection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Clinic Major Player Table 8. Others Major Player Table 9. Drug Concentration Detection Industry Trends Table 10. Drug Concentration Detection Industry Drivers Table 11. Drug Concentration Detection Industry Opportunities and Challenges Table 12. Drug Concentration Detection Industry Restraints Table 13. Global Drug Concentration Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Drug Concentration Detection Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Drug Concentration Detection Market Share by Region (2021-2026) Table 16. Global Drug Concentration Detection Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Drug Concentration Detection Market Share by Region (2027-2032) Table 18. Global Drug Concentration Detection Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Drug Concentration Detection Revenue Market Share by Players (2021-2026) Table 20. Global Drug Concentration Detection Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Drug Concentration Detection Key Players Headquarters & Area Served Table 22. Global Drug Concentration Detection Players, Product Type & Application Table 23. Global Drug Concentration Detection Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Drug Concentration Detection by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Drug Concentration Detection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug Concentration Detection Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Drug Concentration Detection Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Drug Concentration Detection Revenue Market Share by Type (2021-2026) Table 30. Global Drug Concentration Detection Revenue Market Share by Type (2027-2032) Table 31. Global Drug Concentration Detection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug Concentration Detection Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Drug Concentration Detection Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Drug Concentration Detection Revenue Market Share by Application (2021-2026) Table 35. Global Drug Concentration Detection Revenue Market Share by Application (2027-2032) Table 36. Thermo Fisher Scientific Company Information Table 37. Thermo Fisher Scientific Business Overview Table 38. Thermo Fisher Scientific Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Thermo Fisher Scientific Drug Concentration Detection Product Portfolio Table 40. Thermo Fisher Scientific Recent Development Table 41. Abbott Company Information Table 42. Abbott Business Overview Table 43. Abbott Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Abbott Drug Concentration Detection Product Portfolio Table 45. Abbott Recent Development Table 46. ACROBiosystems Company Information Table 47. ACROBiosystems Business Overview Table 48. ACROBiosystems Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. ACROBiosystems Drug Concentration Detection Product Portfolio Table 50. ACROBiosystems Recent Development Table 51. bioMerieux Company Information Table 52. bioMerieux Business Overview Table 53. bioMerieux Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. bioMerieux Drug Concentration Detection Product Portfolio Table 55. bioMerieux Recent Development Table 56. Bio-Rad Laboratories Company Information Table 57. Bio-Rad Laboratories Business Overview Table 58. Bio-Rad Laboratories Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Bio-Rad Laboratories Drug Concentration Detection Product Portfolio Table 60. Bio-Rad Laboratories Recent Development Table 61. Bühlmann Laboratories Company Information Table 62. Bühlmann Laboratories Business Overview Table 63. Bühlmann Laboratories Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bühlmann Laboratories Drug Concentration Detection Product Portfolio Table 65. Bühlmann Laboratories Recent Development Table 66. Danaher Company Information Table 67. Danaher Business Overview Table 68. Danaher Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Danaher Drug Concentration Detection Product Portfolio Table 70. Danaher Recent Development Table 71. Randox Laboratories Company Information Table 72. Randox Laboratories Business Overview Table 73. Randox Laboratories Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Randox Laboratories Drug Concentration Detection Product Portfolio Table 75. Randox Laboratories Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Roche Drug Concentration Detection Product Portfolio Table 80. Roche Recent Development Table 81. Sekisui Medical Company Information Table 82. Sekisui Medical Business Overview Table 83. Sekisui Medical Drug Concentration Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Sekisui Medical Drug Concentration Detection Product Portfolio Table 85. Sekisui Medical Recent Development Table 86. Siemens Healthineers Company Information Table 87. Siemens Healthineers Business Overview Table 88. Siemens Healthineers Drug Concentration Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Siemens Healthineers Drug Concentration Detection Product Portfolio Table 90. Siemens Healthineers Recent Development Table 91. Shanghai Genext Medical Technology Company Information Table 92. Shanghai Genext Medical Technology Business Overview Table 93. Shanghai Genext Medical Technology Drug Concentration Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shanghai Genext Medical Technology Drug Concentration Detection Product Portfolio Table 95. Shanghai Genext Medical Technology Recent Development Table 96. Beijing Chromai Company Information Table 97. Beijing Chromai Business Overview Table 98. Beijing Chromai Drug Concentration Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Beijing Chromai Drug Concentration Detection Product Portfolio Table 100. Beijing Chromai Recent Development Table 101. Beijing IPHASE Company Information Table 102. Beijing IPHASE Business Overview Table 103. Beijing IPHASE Drug Concentration Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Beijing IPHASE Drug Concentration Detection Product Portfolio Table 105. Beijing IPHASE Recent Development Table 106. Beijing Diagreat Company Information Table 107. Beijing Diagreat Business Overview Table 108. Beijing Diagreat Drug Concentration Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Beijing Diagreat Drug Concentration Detection Product Portfolio Table 110. Beijing Diagreat Recent Development Table 111. Beijing Haosi Biotech Company Information Table 112. Beijing Haosi Biotech Business Overview Table 113. Beijing Haosi Biotech Drug Concentration Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Beijing Haosi Biotech Drug Concentration Detection Product Portfolio Table 115. Beijing Haosi Biotech Recent Development Table 116. North America Drug Concentration Detection Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Drug Concentration Detection Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Drug Concentration Detection Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Drug Concentration Detection Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Drug Concentration Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Drug Concentration Detection Revenue by Country (2021-2026) & (US$ Million) Table 122. North America Drug Concentration Detection Revenue by Country (US$ Million) & (2027-2032) Table 123. Europe Drug Concentration Detection Revenue by Type (2021-2026) & (US$ Million) Table 124. Europe Drug Concentration Detection Revenue by Type (2027-2032) & (US$ Million) Table 125. Europe Drug Concentration Detection Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Drug Concentration Detection Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Drug Concentration Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Drug Concentration Detection Revenue by Country (2021-2026) & (US$ Million) Table 129. Europe Drug Concentration Detection Revenue by Country (US$ Million) & (2027-2032) Table 130. China Drug Concentration Detection Revenue by Type (2021-2026) & (US$ Million) Table 131. China Drug Concentration Detection Revenue by Type (2027-2032) & (US$ Million) Table 132. China Drug Concentration Detection Revenue by Application (2021-2026) & (US$ Million) Table 133. China Drug Concentration Detection Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Drug Concentration Detection Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia Drug Concentration Detection Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia Drug Concentration Detection Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia Drug Concentration Detection Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Drug Concentration Detection Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Drug Concentration Detection Revenue by Region (US$ Million) & (2021-2026) Table 140. Asia Drug Concentration Detection Revenue by Region (US$ Million) & (2027-2032) Table 141. SAMEA Drug Concentration Detection Revenue by Type (2021-2026) & (US$ Million) Table 142. SAMEA Drug Concentration Detection Revenue by Type (2027-2032) & (US$ Million) Table 143. SAMEA Drug Concentration Detection Revenue by Application (2021-2026) & (US$ Million) Table 144. SAMEA Drug Concentration Detection Revenue by Application (2027-2032) & (US$ Million) Table 145. SAMEA Drug Concentration Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. SAMEA Drug Concentration Detection Revenue by Country (2021-2026) & (US$ Million) Table 147. SAMEA Drug Concentration Detection Revenue by Country (US$ Million) & (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Drug Concentration Detection Image Figure 2. Global Drug Concentration Detection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Concentration Detection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Blood Detection Image Figure 5. Urine Detection Image Figure 6. Others Image Figure 7. Global Drug Concentration Detection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Drug Concentration Detection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Others Image Figure 12. Global Drug Concentration Detection Market Size (US$ Million) & (2021-2032) Figure 13. Global Drug Concentration Detection Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Drug Concentration Detection Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Drug Concentration Detection Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Drug Concentration Detection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Drug Concentration Detection Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Drug Concentration Detection Revenue Market Share by Type (2021-2032) Figure 20. Global Drug Concentration Detection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drug Concentration Detection Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Drug Concentration Detection Revenue Market Share by Application (2021-2032) Figure 23. North America Drug Concentration Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Drug Concentration Detection Revenue Share by Type (2021-2032) Figure 25. North America Drug Concentration Detection Revenue Share by Application (2021-2032) Figure 26. North America Drug Concentration Detection Revenue Share by Country (2021-2032) Figure 27. United States Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Drug Concentration Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Drug Concentration Detection Revenue Share by Type (2021-2032) Figure 32. Europe Drug Concentration Detection Revenue Share by Application (2021-2032) Figure 33. Europe Drug Concentration Detection Revenue Share by Country (2021-2032) Figure 34. Germany Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Drug Concentration Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Drug Concentration Detection Revenue Share by Type (2021-2032) Figure 44. China Drug Concentration Detection Revenue Share by Application (2021-2032) Figure 45. Asia Drug Concentration Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Drug Concentration Detection Revenue Share by Type (2021-2032) Figure 47. Asia Drug Concentration Detection Revenue Share by Application (2021-2032) Figure 48. Asia Drug Concentration Detection Revenue Share by Region (2021-2032) Figure 49. Japan Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Drug Concentration Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Drug Concentration Detection Revenue Share by Type (2021-2032) Figure 57. SAMEA Drug Concentration Detection Revenue Share by Application (2021-2032) Figure 58. SAMEA Drug Concentration Detection Revenue Share by Country (2021-2032) Figure 59. Brazil Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Drug Concentration Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Detection
  • Urine Detection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Abbott
  • ACROBiosystems
  • bioMerieux
  • Bio-Rad Laboratories
  • Bühlmann Laboratories
  • Danaher
  • Randox Laboratories
  • Roche
  • Sekisui Medical
  • Siemens Healthineers
  • Shanghai Genext Medical Technology
  • Beijing Chromai
  • Beijing IPHASE
  • Beijing Diagreat
  • Beijing Haosi Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Concentration Detection Market by Type
  3. 1.2.1 Global Drug Concentration Detection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Detection
  5. 1.2.3 Urine Detection
  6. 1.2.4 Others
  7. 1.3 Drug Concentration Detection Market by Application
  8. 1.3.1 Global Drug Concentration Detection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Drug Concentration Detection Market Dynamics
  1. 2.1 Drug Concentration Detection Industry Trends
  2. 2.2 Drug Concentration Detection Industry Drivers
  3. 2.3 Drug Concentration Detection Industry Opportunities and Challenges
  4. 2.4 Drug Concentration Detection Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Concentration Detection Market Perspective (2021-2032)
  2. 3.2 Global Drug Concentration Detection Growth Trends by Region
  3. 3.2.1 Global Drug Concentration Detection Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Concentration Detection Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Concentration Detection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Concentration Detection Revenue by Players
  2. 4.1.1 Global Drug Concentration Detection Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Concentration Detection Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Concentration Detection Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Concentration Detection Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Concentration Detection Key Players Headquarters & Area Served
  7. 4.4 Global Drug Concentration Detection Players, Product Type & Application
  8. 4.5 Global Drug Concentration Detection Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Concentration Detection Market CR5 and HHI
  11. 4.6.3 2025 Drug Concentration Detection Tier 1, Tier 2, and Tier 3
5 Drug Concentration Detection Market Size by Type
  1. 5.1 Global Drug Concentration Detection Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Concentration Detection Revenue by Type (2021-2032)
  3. 5.3 Global Drug Concentration Detection Revenue Market Share by Type (2021-2032)
6 Drug Concentration Detection Market Size by Application
  1. 6.1 Global Drug Concentration Detection Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Concentration Detection Revenue by Application (2021-2032)
  3. 6.3 Global Drug Concentration Detection Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Drug Concentration Detection Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Abbott
  8. 7.2.1 Abbott Company Information
  9. 7.2.2 Abbott Business Overview
  10. 7.2.3 Abbott Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Abbott Drug Concentration Detection Product Portfolio
  12. 7.2.5 Abbott Recent Developments
  13. 7.3 ACROBiosystems
  14. 7.3.1 ACROBiosystems Company Information
  15. 7.3.2 ACROBiosystems Business Overview
  16. 7.3.3 ACROBiosystems Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ACROBiosystems Drug Concentration Detection Product Portfolio
  18. 7.3.5 ACROBiosystems Recent Developments
  19. 7.4 bioMerieux
  20. 7.4.1 bioMerieux Company Information
  21. 7.4.2 bioMerieux Business Overview
  22. 7.4.3 bioMerieux Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  23. 7.4.4 bioMerieux Drug Concentration Detection Product Portfolio
  24. 7.4.5 bioMerieux Recent Developments
  25. 7.5 Bio-Rad Laboratories
  26. 7.5.1 Bio-Rad Laboratories Company Information
  27. 7.5.2 Bio-Rad Laboratories Business Overview
  28. 7.5.3 Bio-Rad Laboratories Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bio-Rad Laboratories Drug Concentration Detection Product Portfolio
  30. 7.5.5 Bio-Rad Laboratories Recent Developments
  31. 7.6 Bühlmann Laboratories
  32. 7.6.1 Bühlmann Laboratories Company Information
  33. 7.6.2 Bühlmann Laboratories Business Overview
  34. 7.6.3 Bühlmann Laboratories Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bühlmann Laboratories Drug Concentration Detection Product Portfolio
  36. 7.6.5 Bühlmann Laboratories Recent Developments
  37. 7.7 Danaher
  38. 7.7.1 Danaher Company Information
  39. 7.7.2 Danaher Business Overview
  40. 7.7.3 Danaher Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Danaher Drug Concentration Detection Product Portfolio
  42. 7.7.5 Danaher Recent Developments
  43. 7.8 Randox Laboratories
  44. 7.8.1 Randox Laboratories Company Information
  45. 7.8.2 Randox Laboratories Business Overview
  46. 7.8.3 Randox Laboratories Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Randox Laboratories Drug Concentration Detection Product Portfolio
  48. 7.8.5 Randox Laboratories Recent Developments
  49. 7.9 Roche
  50. 7.9.1 Roche Company Information
  51. 7.9.2 Roche Business Overview
  52. 7.9.3 Roche Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Roche Drug Concentration Detection Product Portfolio
  54. 7.9.5 Roche Recent Developments
  55. 7.10 Sekisui Medical
  56. 7.10.1 Sekisui Medical Company Information
  57. 7.10.2 Sekisui Medical Business Overview
  58. 7.10.3 Sekisui Medical Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sekisui Medical Drug Concentration Detection Product Portfolio
  60. 7.10.5 Sekisui Medical Recent Developments
  61. 7.11 Siemens Healthineers
  62. 7.11.1 Siemens Healthineers Company Information
  63. 7.11.2 Siemens Healthineers Business Overview
  64. 7.11.3 Siemens Healthineers Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Siemens Healthineers Drug Concentration Detection Product Portfolio
  66. 7.11.5 Siemens Healthineers Recent Developments
  67. 7.12 Shanghai Genext Medical Technology
  68. 7.12.1 Shanghai Genext Medical Technology Company Information
  69. 7.12.2 Shanghai Genext Medical Technology Business Overview
  70. 7.12.3 Shanghai Genext Medical Technology Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Shanghai Genext Medical Technology Drug Concentration Detection Product Portfolio
  72. 7.12.5 Shanghai Genext Medical Technology Recent Developments
  73. 7.13 Beijing Chromai
  74. 7.13.1 Beijing Chromai Company Information
  75. 7.13.2 Beijing Chromai Business Overview
  76. 7.13.3 Beijing Chromai Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Beijing Chromai Drug Concentration Detection Product Portfolio
  78. 7.13.5 Beijing Chromai Recent Developments
  79. 7.14 Beijing IPHASE
  80. 7.14.1 Beijing IPHASE Company Information
  81. 7.14.2 Beijing IPHASE Business Overview
  82. 7.14.3 Beijing IPHASE Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Beijing IPHASE Drug Concentration Detection Product Portfolio
  84. 7.14.5 Beijing IPHASE Recent Developments
  85. 7.15 Beijing Diagreat
  86. 7.15.1 Beijing Diagreat Company Information
  87. 7.15.2 Beijing Diagreat Business Overview
  88. 7.15.3 Beijing Diagreat Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Beijing Diagreat Drug Concentration Detection Product Portfolio
  90. 7.15.5 Beijing Diagreat Recent Developments
  91. 7.16 Beijing Haosi Biotech
  92. 7.16.1 Beijing Haosi Biotech Company Information
  93. 7.16.2 Beijing Haosi Biotech Business Overview
  94. 7.16.3 Beijing Haosi Biotech Drug Concentration Detection Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Beijing Haosi Biotech Drug Concentration Detection Product Portfolio
  96. 7.16.5 Beijing Haosi Biotech Recent Developments
8 North America
  1. 8.1 North America Drug Concentration Detection Revenue (2021-2032)
  2. 8.2 North America Drug Concentration Detection Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Concentration Detection Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Concentration Detection Revenue by Type (2027-2032)
  5. 8.3 North America Drug Concentration Detection Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Concentration Detection Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Concentration Detection Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Concentration Detection Revenue by Application (2027-2032)
  9. 8.5 North America Drug Concentration Detection Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Concentration Detection Revenue by Country
  11. 8.6.1 North America Drug Concentration Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Concentration Detection Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Concentration Detection Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Concentration Detection Revenue (2021-2032)
  2. 9.2 Europe Drug Concentration Detection Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Concentration Detection Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Concentration Detection Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Concentration Detection Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Concentration Detection Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Concentration Detection Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Concentration Detection Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Concentration Detection Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Concentration Detection Revenue by Country
  11. 9.6.1 Europe Drug Concentration Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Concentration Detection Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Concentration Detection Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Concentration Detection Revenue (2021-2032)
  2. 10.2 China Drug Concentration Detection Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Concentration Detection Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Concentration Detection Revenue by Type (2027-2032)
  5. 10.3 China Drug Concentration Detection Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Concentration Detection Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Concentration Detection Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Concentration Detection Revenue by Application (2027-2032)
  9. 10.5 China Drug Concentration Detection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Concentration Detection Revenue (2021-2032)
  2. 11.2 Asia Drug Concentration Detection Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Concentration Detection Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Concentration Detection Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Concentration Detection Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Concentration Detection Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Concentration Detection Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Concentration Detection Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Concentration Detection Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Concentration Detection Revenue by Country
  11. 11.6.1 Asia Drug Concentration Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Concentration Detection Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Concentration Detection Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Concentration Detection Revenue (2021-2032)
  2. 12.2 SAMEA Drug Concentration Detection Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Concentration Detection Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Concentration Detection Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Concentration Detection Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Concentration Detection Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Concentration Detection Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Concentration Detection Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Concentration Detection Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Concentration Detection Revenue by Country
  11. 12.6.1 SAMEA Drug Concentration Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Concentration Detection Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Concentration Detection Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst